bupropion hydrochloride
bupropion hydrochloride is a pharmaceutical drug with 13 clinical trials. Historical success rate of 76.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
10 of 13 finished
23.1%
3 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
High Dose Bupropion for Smoking Cessation - Pilot Study
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Study Of 323U66 SR In Major Depressive Disorder
Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy
Clinical Trials (13)
Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
High Dose Bupropion for Smoking Cessation - Pilot Study
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Study Of 323U66 SR In Major Depressive Disorder
Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Bupropion in Helping Adults Stop Smoking
Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion
S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery
Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13